Physician‐assessed changes in clinical signs · atopic eczema
1 finding from 1 review
Withdrawals due to adverse events · atopic eczema
1 finding from 1 review
Physician‐assessed changes in clinical signs · atopic eczema
1 finding from 1 review
Patient‐reported changes in symptoms ‐ not measured · atopic eczema
The review found no eligible studies for this question.
1 finding from 1 review
Investigator Global Assessment · atopic eczema
It is very uncertain whether summary of findings table ‐ NB‐UVB changes investigator Global Assessment compared with PUVA (very low certainty).
1 finding from 1 review
Health‐related quality of life ‐ not measured · atopic eczema
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse events · atopic eczema
1 finding from 1 review
Patient‐reported changes in symptoms · atopic eczema
Summary of findings table ‐ NB‐UVB may leads to higher patient‐reported changes in symptoms compared with placebo (low certainty).
1 finding from 1 review
Investigator Global Assessment · atopic eczema
Summary of findings table ‐ NB‐UVB may leads to higher investigator Global Assessment (short‐term) compared with placebo (low certainty).
1 finding from 1 review
Health‐related quality of life ‐ not measured · atopic eczema
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse outcomes · atopic eczema
1 finding from 1 review
Physician‐assessed changes in clinical signs · atopic eczema
1 finding from 1 review
Patient‐reported changes in symptoms · atopic eczema
1 finding from 1 review
Investigator Global Assessment ‐ not measured · atopic eczema
The review found no eligible studies for this question.
1 finding from 1 review
Health‐related quality of life · atopic eczema
1 finding from 1 review
FEV1 % predicted · children with cystic fibrosis
1 finding from 1 review
Number of people with one or more isolates of S aureus (sensitive strains) · children with cystic fibrosis
Summary of findings ‐ Prophylactic may leads to lower number of people with one or more isolates of S aureus (sensitive… compared with 'as required' anti‐staphylococcal antibiotics (low certainty).
1 finding from 1 review
Number of people with one or more isolates of P aeruginosa · children with cystic fibrosis
Summary of findings ‐ Prophylactic showed no clear difference in number of people with one or more isolates of P aeruginosa compared with 'as required' anti‐staphylococcal antibiotics (low certainty).
1 finding from 1 review
Need for additional antibiotic therapy · children with cystic fibrosis
Summary of findings ‐ Prophylactic showed no clear difference in number of people needing additional antibiotics compared with 'as required' anti‐staphylococcal antibiotics (low certainty).
1 finding from 1 review
Weight (z score) · children with cystic fibrosis
1 finding from 1 review